Siemens healthineers and alibaba damo academy partner to advance AI screening for major diseases

Siemens Healthineers and Alibaba DAMO Academy signed a strategic cooperation agreement at the 9th China International Import Expo in Shanghai on November 6, 2026. The partnership will integrate DAMO Academy's 'One Scan Multi-Screen' AI technology with Siemens Healthineers' medical imaging equipment to aid in the early detection of serious conditions like cancer and cardiovascular diseases. DAMO Academy's technology uses AI to identify subtle lesions in CT images, having previously addressed digestive tumors and aortic dissection, with results in *Science* and *Nature Medicine*. The technology holds FDA Breakthrough Device designation and is in the NMPA green channel review. This collaboration plans to deploy the AI models across Siemens Healthineers' resources to facilitate early detection of high-mortality cancers (pancreatic, gastric, colorectal, esophageal, and liver) and critical cardiovascular issues. The partnership will also work with Ruijin Hospital to validate AI research using photon-counting CT. DAMO Academy's AI has served over 50 million people across 10 countries and regions.